AI-generated summary
This review summarizes in vitro data, preclinical animal studies and clinical reports on photobiomodulation for radiation fibrosis syndrome, a long-term side effect of radiation therapy. The authors report that photobiomodulation reduced acute radiation side effects in phase III randomized studies, but its effect on chronic fibrosis remains to be investigated. They conclude that the evidence shows potential benefits for preventing and reversing fibrosis, a claim that rests on limited data.
- Who or what was studied
- Patients with radiation fibrosis syndrome after radiation therapy, and in vitro, animal and clinical studies
- Limits stated in the abstract
- The abstract describes a review and states that the benefit for chronic radiation fibrosis remains to be investigated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.